Manufacturing - Metal Fabrication
Build Your Comparison
Side-by-side financial analysisStock Comparison
ESAB vs TRI vs JPM vs ICE vs BAC
Revenue, margins, valuation, and 5-year total return — side by side.
Specialty Business Services
Banks - Diversified
Financial - Data & Stock Exchanges
Banks - Diversified
ESAB vs TRI vs JPM vs ICE vs BAC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Manufacturing - Metal Fabrication | Specialty Business Services | Banks - Diversified | Financial - Data & Stock Exchanges | Banks - Diversified |
| Market Cap | $5.35B | $37.56B | $842.21B | $80.15B | $409.69B |
| Revenue (TTM) | $2.91B | $7.66B | $270.79B | $12.64B | $188.75B |
| Net Income (TTM) | $207M | $1.53B | $58.03B | $3.30B | $30.63B |
| Gross Margin | 35.4% | 75.8% | 58.6% | 61.9% | 55.4% |
| Operating Margin | 16.6% | 26.7% | 27.7% | 38.7% | 18.5% |
| Forward P/E | 15.2x | 19.8x | 14.0x | 17.5x | 12.1x |
| Total Debt | $1.43B | $2.12B | $751.15B | $20.28B | $365.90B |
| Cash & Equiv. | $186M | $511M | $469.32B | $837M | $231.84B |
ESAB vs TRI vs JPM vs ICE vs BAC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 22 | Jun 26 | Return |
|---|---|---|---|
| ESAB Corporation (ESAB) | 100 | 175.9 | +75.9% |
| Thomson Reuters Cor… (TRI) | 100 | 75.0 | -25.0% |
| JPMorgan Chase & Co. (JPM) | 100 | 229.1 | +129.1% |
| Intercontinental Ex… (ICE) | 100 | 107.1 | +7.1% |
| Bank of America Cor… (BAC) | 100 | 130.6 | +30.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ESAB vs TRI vs JPM vs ICE vs BAC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Among these 5 stocks, ESAB doesn't own a clear edge in any measured category.
TRI carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 32 yrs, beta 0.32, yield 2.7%
- Lower volatility, beta 0.32, Low D/E 17.8%, current ratio 0.64x
- Beta 0.32, yield 2.7%, current ratio 0.64x
- Beta 0.32 vs ESAB's 1.30, lower leverage
JPM ranks third and is worth considering specifically for growth exposure and long-term compounding.
- Rev growth 14.6%, EPS growth 21.7%
- 435.6% 10Y total return vs BAC's 323.5%
- NIM 2.3% vs BAC's 1.8%
- 14.6% NII/revenue growth vs BAC's -1.9%
ICE is the clearest fit if your priority is quality.
- 26.1% margin vs ESAB's 7.1%
BAC is the #2 pick in this set and the best alternative if valuation efficiency is your priority.
- PEG 0.79 vs TRI's 2.71
- Lower P/E (12.1x vs 17.5x), PEG 0.79 vs 1.97
- +24.4% vs TRI's -54.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 14.6% NII/revenue growth vs BAC's -1.9% | |
| Value | Lower P/E (12.1x vs 17.5x), PEG 0.79 vs 1.97 | |
| Quality / Margins | 26.1% margin vs ESAB's 7.1% | |
| Stability / Safety | Beta 0.32 vs ESAB's 1.30, lower leverage | |
| Dividends | 2.7% yield, 32-year raise streak, vs JPM's 1.6% | |
| Momentum (1Y) | +24.4% vs TRI's -54.7% | |
| Efficiency (ROA) | 8.5% ROA vs BAC's 0.9%, ROIC 11.2% vs 3.2% |
ESAB vs TRI vs JPM vs ICE vs BAC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ESAB vs TRI vs JPM vs ICE vs BAC — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
TRI leads in 2 of 6 categories
ICE leads 1 • BAC leads 1 • JPM leads 1 • ESAB leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ICE leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $270.8B annually — 93.1x ESAB's $2.9B. ICE is the more profitable business, keeping 26.1% of every revenue dollar as net income compared to ESAB's 7.1%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $2.9B | $7.7B | $270.8B | $12.6B | $188.8B |
| EBITDAEarnings before interest/tax | $585M | $3.0B | $81.3B | $6.5B | $36.6B |
| Net IncomeAfter-tax profit | $207M | $1.5B | $58.0B | $3.3B | $30.6B |
| Free Cash FlowCash after capex | $218M | $2.1B | -$119.7B | $4.3B | $12.6B |
| Gross MarginGross profit ÷ Revenue | +35.4% | +75.8% | +58.6% | +61.9% | +55.4% |
| Operating MarginEBIT ÷ Revenue | +16.6% | +26.7% | +27.7% | +38.7% | +18.5% |
| Net MarginNet income ÷ Revenue | +7.1% | +19.9% | +21.6% | +26.1% | +16.2% |
| FCF MarginFCF ÷ Revenue | +7.5% | +27.3% | -15.5% | +33.9% | +6.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +9.9% | +9.8% | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -29.1% | +7.3% | +16.0% | +23.1% | +18.3% |
Valuation Metrics
BAC leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 14.1x trailing earnings, BAC trades at a 44% valuation discount to TRI's 25.3x P/E. Adjusting for growth (PEG ratio), BAC offers better value at 0.92x vs TRI's 3.46x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $5.4B | $37.6B | $842.2B | $80.1B | $409.7B |
| Enterprise ValueMkt cap + debt − cash | $6.6B | $39.2B | $1.12T | $99.6B | $543.8B |
| Trailing P/EPrice ÷ TTM EPS | 23.64x | 25.31x | 15.82x | 24.52x | 14.09x |
| Forward P/EPrice ÷ next-FY EPS est. | 15.22x | 19.80x | 14.03x | 17.46x | 12.07x |
| PEG RatioP/E ÷ EPS growth rate | 3.26x | 3.46x | 1.22x | 2.76x | 0.92x |
| EV / EBITDAEnterprise value multiple | 11.47x | 13.42x | 13.54x | 15.43x | 14.85x |
| Price / SalesMarket cap ÷ Revenue | 1.88x | 5.02x | 3.11x | 6.34x | 2.17x |
| Price / BookPrice ÷ Book value/share | 2.42x | 3.25x | 2.61x | 2.79x | 1.34x |
| Price / FCFMarket cap ÷ FCF | 25.11x | 18.30x | — | 18.69x | 32.48x |
Profitability & Efficiency
TRI leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
JPM delivers a 16.1% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $9 for ESAB. TRI carries lower financial leverage with a 0.18x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.18x. On the Piotroski fundamental quality scale (0–9), ICE scores 9/9 vs JPM's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +9.5% | +12.7% | +16.1% | +11.6% | +10.1% |
| ROA (TTM)Return on assets | +4.2% | +8.5% | +1.3% | +2.3% | +0.9% |
| ROICReturn on invested capital | +11.9% | +11.2% | +5.4% | +7.5% | +3.2% |
| ROCEReturn on capital employed | +13.1% | +13.5% | +8.2% | +9.5% | +4.2% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 | 5 | 9 | 7 |
| Debt / EquityFinancial leverage | 0.65x | 0.18x | 2.18x | 0.70x | 1.21x |
| Net DebtTotal debt minus cash | $1.2B | $1.6B | $281.8B | $19.4B | $134.1B |
| Cash & Equiv.Liquid assets | $186M | $511M | $469.3B | $837M | $231.8B |
| Total DebtShort + long-term debt | $1.4B | $2.1B | $751.1B | $20.3B | $365.9B |
| Interest CoverageEBIT ÷ Interest expense | 4.54x | 13.40x | 0.74x | 6.53x | 0.44x |
Total Returns (Dividends Reinvested)
JPM leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JPM five years ago would be worth $20,251 today (with dividends reinvested), compared to $10,012 for TRI. Over the past 12 months, BAC leads with a +24.4% total return vs TRI's -54.7%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.0% vs TRI's -8.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -21.8% | -30.8% | -3.1% | -11.2% | -2.8% |
| 1-Year ReturnPast 12 months | -29.7% | -54.7% | +21.5% | -19.7% | +24.4% |
| 3-Year ReturnCumulative with dividends | +44.5% | -24.0% | +135.5% | +35.7% | +99.5% |
| 5-Year ReturnCumulative with dividends | +78.2% | +0.1% | +102.5% | +35.8% | +36.1% |
| 10-Year ReturnCumulative with dividends | +78.2% | +132.8% | +435.6% | +192.7% | +323.5% |
| CAGR (3Y)Annualised 3-year return | +13.1% | -8.8% | +33.0% | +10.7% | +25.9% |
Risk & Volatility
Evenly matched — TRI and BAC each lead in 1 of 2 comparable metrics.
Risk & Volatility
TRI is the less volatile stock with a 0.32 beta — it tends to amplify market swings less than ESAB's 1.30 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BAC currently trades 93.5% from its 52-week high vs TRI's 38.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.30x | 0.32x | 0.95x | 0.37x | 0.89x |
| 52-Week HighHighest price in past year | $137.42 | $221.97 | $337.25 | $189.35 | $57.55 |
| 52-Week LowLowest price in past year | $83.17 | $78.60 | $260.31 | $136.67 | $43.66 |
| % of 52W HighCurrent price vs 52-week peak | +64.0% | +38.8% | +92.6% | +74.7% | +93.5% |
| RSI (14)Momentum oscillator 0–100 | 38.7 | 47.6 | 58.4 | 32.3 | 65.4 |
| Avg Volume (50D)Average daily shares traded | 583K | 2.0M | 7.1M | 3.1M | 32.4M |
Analyst Outlook
TRI leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: ESAB as "Buy", TRI as "Buy", JPM as "Buy", ICE as "Buy", BAC as "Buy". Consensus price targets imply 60.3% upside for ESAB (target: $141) vs 8.5% for JPM (target: $339). For income investors, TRI offers the higher dividend yield at 2.72% vs ESAB's 0.41%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $141.00 | $137.67 | $338.78 | $196.43 | $61.13 |
| # AnalystsCovering analysts | 10 | 27 | 61 | 36 | 54 |
| Dividend YieldAnnual dividend ÷ price | +0.4% | +2.7% | +1.6% | +1.4% | +2.4% |
| Dividend StreakConsecutive years of raises | 4 | 32 | 15 | 13 | 12 |
| Dividend / ShareAnnual DPS | $0.36 | $2.34 | $5.13 | $1.93 | $1.27 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.7% | +3.4% | +1.7% | +5.2% |
TRI leads in 2 of 6 categories (Profitability & Efficiency, Analyst Outlook). ICE leads in 1 (Income & Cash Flow). 1 tied.
ESAB vs TRI vs JPM vs ICE vs BAC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ESAB or TRI or JPM or ICE or BAC a better buy right now?
For growth investors, JPMorgan Chase & Co.
(JPM) is the stronger pick with 14. 6% revenue growth year-over-year, versus -1. 9% for Bank of America Corporation (BAC). Bank of America Corporation (BAC) offers the better valuation at 14. 1x trailing P/E (12. 1x forward), making it the more compelling value choice. Analysts rate ESAB Corporation (ESAB) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ESAB or TRI or JPM or ICE or BAC?
On trailing P/E, Bank of America Corporation (BAC) is the cheapest at 14.
1x versus Thomson Reuters Corporation at 25. 3x. On forward P/E, Bank of America Corporation is actually cheaper at 12. 1x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Bank of America Corporation wins at 0. 79x versus Thomson Reuters Corporation's 2. 71x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — ESAB or TRI or JPM or ICE or BAC?
Over the past 5 years, JPMorgan Chase & Co.
(JPM) delivered a total return of +102. 5%, compared to +0. 1% for Thomson Reuters Corporation (TRI). Over 10 years, the gap is even starker: JPM returned +435. 6% versus ESAB's +78. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ESAB or TRI or JPM or ICE or BAC?
By beta (market sensitivity over 5 years), Thomson Reuters Corporation (TRI) is the lower-risk stock at 0.
32β versus ESAB Corporation's 1. 30β — meaning ESAB is approximately 304% more volatile than TRI relative to the S&P 500. On balance sheet safety, Thomson Reuters Corporation (TRI) carries a lower debt/equity ratio of 18% versus 2% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — ESAB or TRI or JPM or ICE or BAC?
By revenue growth (latest reported year), JPMorgan Chase & Co.
(JPM) is pulling ahead at 14. 6% versus -1. 9% for Bank of America Corporation (BAC). On earnings-per-share growth, the picture is similar: JPMorgan Chase & Co. grew EPS 21. 7% year-over-year, compared to -30. 5% for Thomson Reuters Corporation. Over a 3-year CAGR, TRI leads at 4. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ESAB or TRI or JPM or ICE or BAC?
Intercontinental Exchange, Inc.
(ICE) is the more profitable company, earning 26. 1% net margin versus 8. 0% for ESAB Corporation — meaning it keeps 26. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ICE leads at 38. 7% versus 17. 3% for ESAB. At the gross margin level — before operating expenses — TRI leads at 75. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ESAB or TRI or JPM or ICE or BAC more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Bank of America Corporation (BAC) is the more undervalued stock at a PEG of 0. 79x versus Thomson Reuters Corporation's 2. 71x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Bank of America Corporation (BAC) trades at 12. 1x forward P/E versus 19. 8x for Thomson Reuters Corporation — 7. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ESAB: 60. 3% to $141. 00.
08Which pays a better dividend — ESAB or TRI or JPM or ICE or BAC?
All stocks in this comparison pay dividends.
Thomson Reuters Corporation (TRI) offers the highest yield at 2. 7%, versus 0. 4% for ESAB Corporation (ESAB).
09Is ESAB or TRI or JPM or ICE or BAC better for a retirement portfolio?
For long-horizon retirement investors, Intercontinental Exchange, Inc.
(ICE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 37), 1. 4% yield, +192. 7% 10Y return). Both have compounded well over 10 years (ICE: +192. 7%, ESAB: +78. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ESAB and TRI and JPM and ICE and BAC?
These companies operate in different sectors (ESAB (Industrials) and TRI (Industrials) and JPM (Financial Services) and ICE (Financial Services) and BAC (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: ESAB is a small-cap quality compounder stock; TRI is a mid-cap quality compounder stock; JPM is a large-cap deep-value stock; ICE is a mid-cap quality compounder stock; BAC is a large-cap deep-value stock. TRI, JPM, ICE, BAC pay a dividend while ESAB does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.